Skip to Main Content
TRC_PLC_New
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • New Drugs
    • Do Not Crush List
    • Stepwise Treatment of Type 2 Diabetes
    • Contraceptives
    • Antidepressants
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Hematology & Oncology
  4. Chemotherapy-Induced Adverse Effects
  5. Osteoporosis

Osteoporosis

  • Anemia (44)
  • Blood Products (2)
  • Breast Cancer (72)
  • Cancer (20)
  • Cervical Cancer (9)
  • Chemotherapy (7)
  • Chemotherapy-Induced Adverse Effects (27)
    • Dry Mouth (5)
    • Mucositis (7)
    • Nausea and Vomiting (16)
    • Osteoporosis (4)
  • Colon Cancer (19)
  • Drugs/Products That May Increase Cancer Risk (112)
  • Gastrointestinal Cancers (29)
  • Hemophilia (3)
  • Hemorrhage (2)
  • Leukemia (1)
  • Lung Cancer (81)
  • Ovarian Cancer (5)
  • Prostate Cancer (27)
  • Resources (75)
  • Sickle Cell Disease (3)
  • Skin Cancer (25)
1 - 4 of 4 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Guideline: Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: An advisory statement from theAmerican Dental Association Council on Scientific Affairs (2008) August 2006
Commentary: Bisphosphonates-Associated Jaw Osteonecrosis August 2006
Patient Education: Bisphosphonates and Jaw Bone Damage August 2006
Article: Boniva (ibandronate), a once-MONTHLY bisphosphonate for osteoporosis May 2005
  • 1
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved